BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34438996)

  • 1. Successful Intratracheal Treatment of Phage and Antibiotic Combination Therapy of a Multi-Drug Resistant
    Duplessis C; Warawa JM; Lawrenz MB; Henry M; Biswas B
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections.
    Chen B; Benavente LP; Chittò M; Wychowaniec JK; Post V; D'Este M; Constant C; Zeiter S; Feng W; Moreno MG; Trampuz A; Wagemans J; Onsea J; Richards RG; Lavigne R; Moriarty TF; Metsemakers WJ
    J Control Release; 2023 Dec; 364():159-173. PubMed ID: 37866403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
    Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
    J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation.
    Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N
    Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Killing and Re-Sensitization of
    Engeman E; Freyberger HR; Corey BW; Ward AM; He Y; Nikolich MP; Filippov AA; Tyner SD; Jacobs AC
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
    Vinodkumar CS; Kalsurmath S; Neelagund YF
    Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
    Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice.
    Chow MYT; Chang RYK; Li M; Wang Y; Lin Y; Morales S; McLachlan AJ; Kutter E; Li J; Chan HK
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Lytic Phages Protect Cells and Mice against
    Chen F; Cheng X; Li J; Yuan X; Huang X; Lian M; Li W; Huang T; Xie Y; Liu J; Gao P; Wei X; Wang Z; Wu M
    J Virol; 2021 Mar; 95(8):. PubMed ID: 33472935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing.
    Lawrenz MB; Biller AE; Cramer DE; Kraenzle JL; Sotsky JB; Vanover CD; Yoder-Himes DR; Pollard A; Warawa JM
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25857733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model.
    Rezk N; Abdelsattar AS; Elzoghby D; Agwa MM; Abdelmoteleb M; Aly RG; Fayez MS; Essam K; Zaki BM; El-Shibiny A
    J Genet Eng Biotechnol; 2022 Sep; 20(1):133. PubMed ID: 36094767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by
    Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A
    Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
    Abd El-Aziz AM; Elgaml A; Ali YM
    J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa.
    Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y
    J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen.
    Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L
    Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.